Knowing the Score: Identifying Patients at High Risk of Liver Fibrosis from Non-Alcoholic Fatty Liver Disease (NAFLD)

IE users – if you are experiencing issues trying to register for this webinar, please use Chrome, Safari or Firefox.

Tues., Dec. 9, 2014
12:00 pm ET/9:00 am PT

Click here to register for this webinar where Nathan Bass, MD, will discuss Non-Alcoholic Fatty Liver Disease (NAFLD) which is the most common cause of chronic liver disease in the United States.  Dr. Bass will define what NAFLD is and why it is of growing concern in relationship to type 2 diabetes and explain the NAFLD Fibrosis Score and its importance.

Presented by Nathan M. Bass, MD, PhD
Professor Emeritus of Medicine
Former Medical Director, UCSF Liver Transplantation Service
Division of Gastroenterology
UCSF Medical Center and School of Medicine
San Francisco, California

 ONE contact hour toward ASCLS P.A.C.E. ® credit will be available to participating laboratory professionals who attend the webinar and complete the post evaluation. 

Audience: Internal medicine, adult medicine physicians, nurse practitioners, physician assistants; infectious disease specialists, clinical and lab healthcare providers. 

INVITATION - Download printable invitation PDF